SCHEMBL7036914

SCHEMBL7036914

CNC(=O)Cc1ccc([C@@H](Cc2ccccc2)NC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)cc1

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ADRB3 P13945 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7039488 1.00 ADRB3 (0.82) ADRB3
SCHEMBL7039490 1.00 ADRB3 (0.82) ADRB3
SCHEMBL7039483 1.00 ADRB3 (0.82) ADRB3
SCHEMBL7039379 0.92 ADRB3 (0.86) ADRB3
SCHEMBL7041489 0.92 ADRB3 (0.86) ADRB3
SCHEMBL7036818 0.90 ADRB3 (1.00) ADRB3
SCHEMBL7039320 0.90 ADRB3 (1.00) ADRB3
SCHEMBL7036822 0.90 ADRB3 (1.00) ADRB3
SCHEMBL7037490 0.90 ADRB3 (1.00) ADRB3
SCHEMBL7037346 0.88 ADRB3 (0.80) ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 — — EP claimed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 — — EP claimed
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 — — EP disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 — — EP disclosed
Send feedback